Speaker Biography
"Emerging research indicates that the public has reservations about biotechnology patents and feels that industry involvement may compromise credibility…. Governance schemes should be developed that recognize and protect the public interest." - Timothy Caulfield, writing in Nature Biotechnology


Timothy Caulfield, LL.M., analyzes the impact of gene patents on health care and health policy. He is the Research Director of Health Law at the University of Alberta. In 2002, he received a Canada research Chair in Health Law and Policy. Additionally, Caulfield is a professor in the Faculty of Law and the School of Public Health. He has been a visiting scholar at the Hastings Center for Bioethics in New York, the University of Houston's Health Law and Policy Institute, and Stanford University's Program in Genomics, Ethics and Society. The Canadian government has called upon him to serve on national advisory committees relating to health research, biotechnology, social policy, and genetics ethics. Caulfield completed both his B.Sc. and LL.B. degrees at the University of Alberta, and his LL.M. at Dalhousie University.

Along with Bryn Williams-Jones, Caulfield is the author of The Commercialization of Genetic Research - Legal, Ethical, and Policy Issues, published by Springer (1999). Caulfield is also the author of more than 100 scholarly articles and book chapters.

Selected Publications:

Timothy Caulfield and Tania Bubela, "Why a Criminal Ban?: Analyzing the Arguments Against Somatic Cell Nuclear Transfer in the Canadian Parliamentary Debate," 7 Am. J. of Bioethics 51 (2007).

Timothy Caulfield, Robert M. Cook-Deegan, F. Scott Kieff, and John P. Walsh, "Evidence and Anecdotes: An Analysis of Human Gene Patenting Controversies," 24 Nature Biotech. 1091-94 (2006).

Timothy Caulfield and Barbara von Tigerstrom, "Gene Patents, Health Care Policy and Licensing Schemes," 24 Trends Biotech. 251-54 (2006).

Timothy Caulfield and Roger Brownsword, "Human Dignity: A Guide to Policy Making in the Biotechnology Era?" 7 Nature Reviews Genetics 72-76 (2006).

Timothy Caulfield, "Stem Cell Patents and Social Controversy: A Speculative View From Canada," 7 Medical Law Int'l 219-32 (2006).

Timothy Caulfield, Suzanne DeBow, and Tania Bubela, "Stem Cells, Politics and the Process Paradigm," 15 Health L. Rev. (U. Alberta) 50-52 (2006).

Timothy Caulfield, Edna Einsiedel, Jon F. Merz, and Dianne Nicol, "Trust, Patents, and Public Perceptions: The Governance of Controversial Biotechnology Research," 24 Nature Biotech. 1352-54 (2006).

Timothy Caulfield, "Commentary: An Independent Voice?: Conflicts of Interest and Research on Ethical, Legal and Social Issues," 13 Health L. Rev. (U. Alberta) 114-16 (2005).

Timothy Caulfield, "Legal and Ethical Issues Associated with Patient Recruitment in Clinical Trials: The Case of Competitive Enrolment," 13 Health L. Rev. (U. Alberta) 58-61 (2005).

Timothy Caulfield and Tania Bubela, "Do the Print Media 'Hype' Genetic Research? A Comparison of Newspaper Stories and Peer-Reviewed Research Papers," 170 Canadian Med. Ass'n J. 1399-1407 (2004).

Timothy Caulfield, Ross Upshur, and Abdallah Daar, "DNA Databanks and Consent: A Suggested Policy Option Involving an Authorization Model," 4 BioMed Central Med. Ethics E1 (2003).

Timothy Caulfield, "From Human Genes to Stem Cells: New Challenges for Patent Law?" 21 Trends Biotech. 101-03 (2003).

Timothy Caulfield, "Sustainability and the Balancing of the Healthcare and Innovation Agendas: The Commercialization of Genetic Research," 66 Sask. L. Rev. 629-45 (2003).

Timothy Caulfield, P. Saradhi Puttagunta, and Glenn Griener, "Conflict of Interest in Clinical Research: Direct Payment to the Investigators For Finding Human Subjects and Health Information," 10 Health L. Rev. (U. Alberta) 30-32 (2002).

Timothy Caulfield and Glenn Griener, "Conflicts of Interest in Clinical Research: Addressing the Issue of Physician Remuneration," 30 J.L. Med. & Ethics 305-08 (2002).

Timothy Caulfield and Tim Outerbridge, "DNA Databanks, Public Opinion and the Law," 25 Clinical & Investigative Med. 252-56 (2002).

Timothy Caulfield, "Ethics Watch: Genetics Services and Market Forces," Nature Reviews Genetics 734 (2002).

Timothy Caulfield, "Gene Banks and Blanket Conditions," Nature Reviews Genetics 577 (2002).

Timothy Caulfield, Richard Gold, and Peter Ray, "Gene Patents and the Standard of Care," 167 Canadian Med. Ass'n J. 256-57 (2002).

Timothy Caulfield and Richard Gold, "The Moral Tollbooth: A Method that Makes Use of the Patent System to Address Ethical Concerns in Biotechnology," 359 Lancet 2268-70 (2002).

[ Back to Conference ]

© 2007 WhoOwnsYourBody.org. All rights reserved.